How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Annals of Surgical Oncology - United States
doi 10.1245/s10434-016-5246-8
Full Text
Open PDFAbstract
Available in full text
Date
May 9, 2016
Authors
Publisher
Springer Science and Business Media LLC